| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/29/2002 | WO2002028858A3 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 08/29/2002 | WO2002028346A3 Association of the cb1 receptor antagonist and sibutramin, for treating obesity |
| 08/29/2002 | WO2002022621A3 INTERPHENYLENE 7-OXABICYCLIC[2.2.1]HEPTANE OXAZOLES AS PROSTAGLANDIN F2a ANTAGONISTS |
| 08/29/2002 | WO2002022620A3 Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin f2$g(a) antagonists |
| 08/29/2002 | WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo |
| 08/29/2002 | WO2002018383A3 Aza heterocyclic derivatives and their therapeutic use |
| 08/29/2002 | WO2002018324A3 Immunoregulatory compounds, derivatives thereof and their use |
| 08/29/2002 | WO2002016369A3 Novel macrocycles and uses thereof |
| 08/29/2002 | WO2002015894A3 Use of vitamin d derivatives as bone resorption inhibitors |
| 08/29/2002 | WO2002010403A3 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 08/29/2002 | WO2002010388A3 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 08/29/2002 | WO2002008256A3 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 08/29/2002 | WO2002003988A3 Use of substituted indole compounds for treating neuropeptide y-related conditions |
| 08/29/2002 | WO2002002525A3 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 08/29/2002 | WO2002002506A3 Compounds to treat alzheimer's disease |
| 08/29/2002 | WO2002000641A3 Spla2 inhibitors |
| 08/29/2002 | WO2002000227A3 Use of lanthanum compounds for the treatment of bone diseases |
| 08/29/2002 | WO2001097805A3 Solid valsartan pharmaceutical compositions |
| 08/29/2002 | WO2001096547A3 Human kinases |
| 08/29/2002 | WO2001095943A3 Prodrug compounds with an oligopeptide having an isoleucine residue |
| 08/29/2002 | WO2001091808A3 Bioconjugates of nanoparticles as radiopharmaceuticals |
| 08/29/2002 | WO2001087845A3 N-containing heterocyclic compounds and their use as 5-ht antagonists |
| 08/29/2002 | WO2001085093A3 Compounds and methods for modulating cerebral amyloid angiopathy |
| 08/29/2002 | WO2001082975A3 Membrane-permeant peptide complexes for medical imaging |
| 08/29/2002 | WO2001079284A3 Therapeutic compounds and methods for formulating v3, a versican isoform |
| 08/29/2002 | WO2001077338A3 Human protein kinases and protein kinase-like enzymes |
| 08/29/2002 | WO2001071342A3 Identification of mast cell/basophil activation inhibitors |
| 08/29/2002 | WO2001068848A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/29/2002 | WO2001061055A3 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 08/29/2002 | WO2001060408A3 Microcompetiton and human disease |
| 08/29/2002 | WO2001037785A9 Novel methods and compositions involving opioids and antagonists thereof |
| 08/29/2002 | WO2001035941A8 Novel composition based on a thiazolidinedione and metformin and use |
| 08/29/2002 | WO2001017530A9 Iron chelators and uses thereof |
| 08/29/2002 | WO2001012584A3 Pharmaceutical compounds |
| 08/29/2002 | WO2001008670A3 Methods and compositions for alleviating stuttering |
| 08/29/2002 | WO2001007481A9 Antitumor antibodies, proteins, and uses thereof |
| 08/29/2002 | WO2000067746A9 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 08/29/2002 | WO2000066737A9 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY |
| 08/29/2002 | WO2000066709A9 Zymogen activation system |
| 08/29/2002 | WO2000066104A9 Ace-2 inhibiting compounds and methods of use thereof |
| 08/29/2002 | WO2000059515A9 Immunomodulating polymers |
| 08/29/2002 | WO2000056866A9 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 08/29/2002 | WO2000055330A9 Polysaturated fatty acid (pufa) elongase from caenorhabditis elegans |
| 08/29/2002 | WO2000040543A9 Skin whitener |
| 08/29/2002 | WO2000037502A9 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/29/2002 | WO2000010981A9 Quinazoline derivatives |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020120948 Modulating gene expression by regulation of cell proliferation; regulated transgene expression in lymphocytes by selective increase in the number of lymphocytes upon exposure to an antigen |
| 08/29/2002 | US20020120152 Aminoaryl oxazolidinone N-oxides |
| 08/29/2002 | US20020120149 Substituted hydrazine derivatives |
| 08/29/2002 | US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 08/29/2002 | US20020120145 Inhibiting farnesyl protein transferase. |
| 08/29/2002 | US20020120139 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 08/29/2002 | US20020120123 Human vascular endothelial growth factor 2 |
| 08/29/2002 | US20020120103 17 human secreted proteins |
| 08/29/2002 | US20020120098 Enhanced stimulation of erythropoiesis |
| 08/29/2002 | US20020120013 Regulation of phospholipase D activity |
| 08/29/2002 | US20020120010 Increasing and enhancing the quantity and quality of normal spermatozoa in male mammals |
| 08/29/2002 | US20020120003 Methods for decreasing beta amyloid protein |
| 08/29/2002 | US20020119999 Imidazole dione or one, thione derivatives as antitumor and antiinflammatory agents, also treats cardiovascular disease, nephropathies and retinopathies |
| 08/29/2002 | US20020119988 Modulators of TNF-alpha signaling |
| 08/29/2002 | US20020119987 Analgesics, anesthetic; side effect reduction |
| 08/29/2002 | US20020119986 Heteroaryl- phenyl heterobicyclic factor Xa inhibitors |
| 08/29/2002 | US20020119983 Novel isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof |
| 08/29/2002 | US20020119977 Antitumor agents; antiinflammatory agents; analgesics; antipyretic agent |
| 08/29/2002 | US20020119976 Tetracyclic derivatives, process of preparation and use |
| 08/29/2002 | US20020119975 Autoimmune disease; antiinflammatory agents; antiallergens; antiproliferative agents; anticancer agents |
| 08/29/2002 | US20020119973 Antiinflammatory agents |
| 08/29/2002 | US20020119971 Antiinflammatory agents; skin disorders; central nervous system disorders |
| 08/29/2002 | US20020119967 Autoimmune diseases; administering phosphodiesterases inhibitor |
| 08/29/2002 | US20020119964 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase |
| 08/29/2002 | US20020119961 Bridged piperazine derivatives |
| 08/29/2002 | US20020119960 Drug resistance therapy |
| 08/29/2002 | US20020119956 Using thalidomine |
| 08/29/2002 | US20020119955 Modified prodrug forms of AP/AMP |
| 08/29/2002 | US20020119953 Sickle cell anemia |
| 08/29/2002 | US20020119945 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and uses thereof |
| 08/29/2002 | US20020119943 Novel mammalian gene,bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes |
| 08/29/2002 | US20020119940 Gene expression and delivery systems and uses |
| 08/29/2002 | US20020119932 RGD-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects |
| 08/29/2002 | US20020119926 Inhibitors of IAPP fibril formation and uses thereof |
| 08/29/2002 | US20020119924 Combination therapy using a TNF binding protein for treating TNF-mediated diseases |
| 08/29/2002 | US20020119923 Administering macrophage derived compound |
| 08/29/2002 | US20020119912 Synergistic mixture; therapy for psychological disorders |
| 08/29/2002 | US20020119554 Arginase II |
| 08/29/2002 | US20020119548 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 08/29/2002 | US20020119539 Isolation of purified tgf -beta1 and tgf -beta2 from bone tissue |
| 08/29/2002 | US20020119519 Nucleotide sequences coding preferential polyeptide for use in the treatment of cancer, kidney and respiratory disorders |
| 08/29/2002 | US20020119518 Peptide for use in treatment and diagnosis of heart defects |
| 08/29/2002 | US20020119502 Screening drugs for use in the treatment of mammary gland cancer; obtain animal, inject or orally administer anticarcinogeneic agent, monitor animal for development of cancer |
| 08/29/2002 | US20020119153 Antibody conjugate formulations for selectively inhibiting VEGF |
| 08/29/2002 | US20020119151 CD154 blockade therapy for therapeutic protein inhibitor syndrome |
| 08/29/2002 | US20020119144 Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
| 08/29/2002 | US20020119143 Antithrombin III for disorders caused by angiogenesis |
| 08/29/2002 | US20020119127 Method and system for optimizing minigenes and peptides encoded thereby |
| 08/29/2002 | US20020119119 Administering natural killer cell activating cytokine or flavonoid, wherein cytokine is not IL-2 or IFN-alpha; administering histamine or serotonin or H2 receptor agonists to inhibit production or release of hydrogen peroxide |
| 08/29/2002 | DE10107683A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical |
| 08/29/2002 | DE10106970A1 Neues Benzoylguanidinsalz New Benzoylguanidinsalz |
| 08/29/2002 | CA2453078A1 2-thio-substituted imidazole derivatives and their use in pharmacy |
| 08/29/2002 | CA2442742A1 Quinazoline derivatives |